Health for Life Capital™

Supporting innovation in the health and nutrition fields

Seventure Partners, a leading European venture capital company investing in innovative technologies and a subsidiary of Natixis Global AM, successfully completed the final closing for the Health for Life Capital™ innovation fund in December 2015, increasing the total amount of funds available to €160m. As the first European investment vehicle essentially devoted to the microbiome, Health for Life Capital™ has been funding the development of innovative European and North-American firms active in the biotech, nutrition, medtech and connected health fields since its inception in 2013. The fund’s management strategy attracted both financial investors and strategic trade investors like Danone and Novartis.

Abstract from Target 2016, Natixis corporate document